David Nakasone
Head of Miscellations
Replay available
Tarsus Pharmaceuticals, Inc. (TARS) Q1 2026 Earnings Call
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bobby Azamian
Chief Executive Officer & Chairman
Aziz Matawala
Chief Commercial Officer
Jeff Farrell
Chief Financial Officer & Chief Strategy Officer
Dennis Ding
Analyst
Frank Bispo
Analyst, Lifestyle Capital
Jenna Dibner
Analyst, Barclays
Masahira Ali-Mohamed
Analyst, Eppenheimer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tarsus Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.098 Good afternoon and welcome to TARSA's First Quarter 2026 Financial Results Conference 00:00:05.098 -- 00:00:10.306 Call. As a reminder, this call is being recorded and all participants are in a listen-only 00:00:10.306 -- 00:00:14.512 mode. After the speaker's presentation, there will be a question and answer session. 00:00:14.512 -- 00:00:20.060 At this time, I would like to turn the call over to David Nakasone, Head of Miscellations, 00:00:20.060 -- 00:00:22.444 to lead off the call. David, you may begin. 00:00:22.444 -- 00:00:24.444 Thank 00:00:25.388 -- 00:00:30.137 you. Before we begin, I encourage everyone to visit the investor section of the TARCIS 00:00:30.137 -- 00:00:35.242 website to view the earnings release and related materials we will be discussing today. 00:00:35.242 -- 00:00:39.225 Joining me on the call this afternoon are Bobby Azamian, our Chief Executive Officer 00:00:39.225 -- 00:00:44.210 and Chairman, Aziz Matawala, our Chief Commercial Officer, and Jeff Farrell, our Chief 00:00:44.210 -- 00:00:47.853 Financial Officer and Chief Strategy Officer. 00:00:47.853 -- 00:00:52.958 I'd like to draw your attention to slide three, which contains our forward-looking statements. 00:00:52.958 -- 00:00:56.958 During this call, we will be making forward-looking statements that are based on our 00:00:56.958 -- 00:01:02.007 current expectations and beliefs. These statements are subject to certain risks and 00:01:02.007 -- 00:01:06.053 uncertainties, and our actual results may differ materially. 00:01:06.053 -- 00:01:10.801 I encourage you to consult the risk factors contained in our SEC filings for additional 00:01:10.801 -- 00:01:12.303 details. 00:01:12.303 -- 00:01:15.989 With that, I'll turn the call over to Bobby. 00:01...